Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1980 Feb;39(2):435–441.

The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.

R Bomford
PMCID: PMC1538081  PMID: 6248283

Abstract

Corynebacterium parvum was the only adjuvant of those tested which consistently potentiated delayed-type hypersensitivity (DTH) to sheep red blood cells (SRBC) in the mouse, although this required the antigen-adjuvant mixture to be injected subcutaneously in the footpad rather than the flank. For induction of DTH to ovalbumin (OVA) in the guinea pig, C. parvum and MDP could be substituted for the mycobacteria in FCA. C. parvum was effective in aqueous solution provided that the OVA was absorbed onto alhydrogel. Saponin also potentiated DTH when injected with OVA in aqueous solution. C. parvum was the sole adjuvant of those tested to promote protective cell-mediated immunity (CMI) to M4 fibrosarcoma cells. It is concluded that C. parvum is a promising candidate adjuvant for promoting CMI induction without recourse to a water-in-oil emulsion.

Full text

PDF
435

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Athanassiades T. J. Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in mice: enhancement of cell-mediated immunity by subcutaneous administration of adjuvant and antigen. Infect Immun. 1977 Nov;18(2):416–423. doi: 10.1128/iai.18.2.416-423.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bomford R. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells. Br J Cancer. 1975 Nov;32(5):551–557. doi: 10.1038/bjc.1975.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bomford R., McHardy N. Corynebacterium parvum as an adjuvant for Trypanosoma cruzi epimastigote vaccines: a comparison with saponin and Bordetella pertussis. Parasitology. 1979 Feb;78(1):77–87. doi: 10.1017/s0031182000048605. [DOI] [PubMed] [Google Scholar]
  4. Bomford R. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clin Exp Immunol. 1980 Feb;39(2):426–434. [PMC free article] [PubMed] [Google Scholar]
  5. Crowle A. J., Atkins A., May M. Induction of delayed hypersensitivity to protein antigens in mice without Freund adjuvants. J Allergy Clin Immunol. 1977 Jul;60(1):14–26. doi: 10.1016/0091-6749(77)90078-1. [DOI] [PubMed] [Google Scholar]
  6. Dalsgaard K. Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines. Arch Gesamte Virusforsch. 1974;44(3):243–254. [PubMed] [Google Scholar]
  7. Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317–1325. doi: 10.1016/0006-291x(74)90458-6. [DOI] [PubMed] [Google Scholar]
  8. Garnham P. C., Humphrey J. H. Problems in leishmaniasis related to immunology. Curr Top Microbiol Immunol. 1969;48:29–42. doi: 10.1007/978-3-642-46163-7_2. [DOI] [PubMed] [Google Scholar]
  9. Gauthier-Rahman S., Halpern B., Besluau D. Effect of Corynebacterium parvum on the immune response of the guinea pig to ovalbumin. Dev Biol Stand. 1977 Apr 13;38:205–214. [PubMed] [Google Scholar]
  10. Hawrylko E., Mackaness G. B. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen. J Natl Cancer Inst. 1973 Nov;51(5):1677–1682. doi: 10.1093/jnci/51.5.1677. [DOI] [PubMed] [Google Scholar]
  11. Hellström K. E., Hellström I. Cellular immunity against tumor antigens. Adv Cancer Res. 1969;12:167–223. doi: 10.1016/s0065-230x(08)60331-0. [DOI] [PubMed] [Google Scholar]
  12. Herberman R. B. Cell-mediated immunity to tumor cells. Adv Cancer Res. 1974;19(0):207–263. doi: 10.1016/s0065-230x(08)60055-x. [DOI] [PubMed] [Google Scholar]
  13. Lagrange P. H., Mackaness G. B., Miller T. E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med. 1974 Jun 1;139(6):1529–1539. doi: 10.1084/jem.139.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lallouette P., Richou R., Richou H. Méthode simple d'évaluation de l'activité adjuvante des sapomines. C R Acad Sci Hebd Seances Acad Sci D. 1970 Jun 1;270(22):2729–2730. [PubMed] [Google Scholar]
  15. Larsh J. E., Jr, Weatherly N. F. Cell-mediated immunity in certain parasitic infections. Curr Top Microbiol Immunol. 1974;67:113–137. doi: 10.1007/978-3-642-65912-6_4. [DOI] [PubMed] [Google Scholar]
  16. Liew F. Y. Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol. 1977 Oct;7(10):714–718. doi: 10.1002/eji.1830071013. [DOI] [PubMed] [Google Scholar]
  17. Mackaness G. B., Lagrange P. H., Ishibashi T. The modifying effect of BCG on the immunological induction of T cells. J Exp Med. 1974 Jun 1;139(6):1540–1552. doi: 10.1084/jem.139.6.1540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mathé G., Pouillart P., Lapeyraque F. Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells. Br J Cancer. 1969 Dec;23(4):814–824. doi: 10.1038/bjc.1969.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mauel J., Behin R. Cell-mediated and humoral immunity to protozoan infections. Transplant Rev. 1974;19(0):121–146. doi: 10.1111/j.1600-065x.1974.tb00130.x. [DOI] [PubMed] [Google Scholar]
  20. McCarthy R. E., Arnold L. W., Babcock G. F. Dextran sulphate: an adjuvant for cell-mediated immune responses. Immunology. 1977 Jun;32(6):963–974. [PMC free article] [PubMed] [Google Scholar]
  21. Miller T. E., Mackaness G. B., Lagrange P. H. Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells. J Natl Cancer Inst. 1973 Nov;51(5):1669–1676. doi: 10.1093/jnci/51.5.1669. [DOI] [PubMed] [Google Scholar]
  22. NEVEU T., BRANELLEC A., BIOZZI G. PROPRI'ET'ES ADJUVANTES DE CORYNEBACTERIUM PARVUM SUR LA PRODUCTION D'ANTICORPS ET SUR L'INDUCTION DE L'HYPERSENSIBILIT'E RETARD'EE ENVERS LES PROT'EINES CONJUGU'EES. Ann Inst Pasteur (Paris) 1964 May;106:771–777. [PubMed] [Google Scholar]
  23. Parr I. Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour. Br J Cancer. 1972 Jun;26(3):174–182. doi: 10.1038/bjc.1972.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Renoux G., Renoux M., Teller M. N., McMahon S., Guillaumin J. M. Potentiation of T-cell mediated immunity by levamisole. Clin Exp Immunol. 1976 Aug;25(2):288–296. [PMC free article] [PubMed] [Google Scholar]
  25. Richou R., Lallouette P., Richou H. Les adjuvants de l'immunité. Mode d'action de la saponine en relation avec son pouvoir inflammatoire. C R Acad Sci Hebd Seances Acad Sci D. 1967 Oct 30;265(18):1349–1352. [PubMed] [Google Scholar]
  26. Scott M. T. Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen. Cell Immunol. 1974 Aug;13(2):251–263. doi: 10.1016/0008-8749(74)90243-3. [DOI] [PubMed] [Google Scholar]
  27. Scott M. T. Potentiation of the tumor-specific immune response by Corynebacterium parvum. J Natl Cancer Inst. 1975 Jul;55(1):65–72. doi: 10.1093/jnci/55.1.65. [DOI] [PubMed] [Google Scholar]
  28. Snippe H., Belder M., Willers J. M. Dimethyl diotadecyl ammonium bromide as adjuvant for delayed hypersensitivity in mice. Immunology. 1977 Dec;33(6):931–936. [PMC free article] [PubMed] [Google Scholar]
  29. Strannegård O., Roupe G. Adjuvant effect of lysolecithin analogues on the development of contact sensitivity in mice. Int Arch Allergy Appl Immunol. 1976;51(2):198–205. doi: 10.1159/000231592. [DOI] [PubMed] [Google Scholar]
  30. Tuttle R. L., North R. J. Mechanisms of antitumor action of Corynebacterium parvum: replicating short-lived T cells as the mediators of potentiated tumor-specific immunity. J Reticuloendothel Soc. 1976 Sep;20(3):209–216. [PubMed] [Google Scholar]
  31. WHITE R. G., COONS A. H., CONNOLLY J. M. Studies on antibody production. IV. The role of a wax fraction of Mycobacterium tuberculosis in adjuvant emulsions on the production of antibody to egg albumin. J Exp Med. 1955 Jul 1;102(1):83–104. doi: 10.1084/jem.102.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. White R. G. Role of adjuvants in the production of delayed hypersensitivity. Br Med Bull. 1967 Jan;23(1):39–45. doi: 10.1093/oxfordjournals.bmb.a070514. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES